ReviewJournal of hematology & oncology2020

Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer.

Patrycja Gralewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.